1. Home
  2. TSSI vs STOK Comparison

TSSI vs STOK Comparison

Compare TSSI & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSSI
  • STOK
  • Stock Information
  • Founded
  • TSSI 2004
  • STOK 2014
  • Country
  • TSSI United States
  • STOK United States
  • Employees
  • TSSI N/A
  • STOK N/A
  • Industry
  • TSSI Professional Services
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • TSSI Consumer Discretionary
  • STOK Health Care
  • Exchange
  • TSSI Nasdaq
  • STOK Nasdaq
  • Market Cap
  • TSSI 353.7M
  • STOK 379.6M
  • IPO Year
  • TSSI N/A
  • STOK 2019
  • Fundamental
  • Price
  • TSSI $7.38
  • STOK $7.69
  • Analyst Decision
  • TSSI
  • STOK Strong Buy
  • Analyst Count
  • TSSI 0
  • STOK 6
  • Target Price
  • TSSI N/A
  • STOK $26.00
  • AVG Volume (30 Days)
  • TSSI 929.9K
  • STOK 987.9K
  • Earning Date
  • TSSI 05-21-2025
  • STOK 05-05-2025
  • Dividend Yield
  • TSSI N/A
  • STOK N/A
  • EPS Growth
  • TSSI 7042.86
  • STOK N/A
  • EPS
  • TSSI 0.24
  • STOK N/A
  • Revenue
  • TSSI $148,144,000.00
  • STOK $36,555,000.00
  • Revenue This Year
  • TSSI N/A
  • STOK $27.80
  • Revenue Next Year
  • TSSI N/A
  • STOK $9.53
  • P/E Ratio
  • TSSI $30.75
  • STOK N/A
  • Revenue Growth
  • TSSI 172.33
  • STOK 316.34
  • 52 Week Low
  • TSSI $0.68
  • STOK $5.35
  • 52 Week High
  • TSSI $18.26
  • STOK $17.58
  • Technical
  • Relative Strength Index (RSI)
  • TSSI N/A
  • STOK 53.59
  • Support Level
  • TSSI N/A
  • STOK $7.31
  • Resistance Level
  • TSSI N/A
  • STOK $7.99
  • Average True Range (ATR)
  • TSSI 0.00
  • STOK 0.61
  • MACD
  • TSSI 0.00
  • STOK 0.23
  • Stochastic Oscillator
  • TSSI 0.00
  • STOK 88.64

About TSSI TSS Inc. Common Stock

TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: facilities, and systems integration. It generates the majority of its revenue from Systems integration services. It generates revenue from the United States.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: